CRYSTAL GOINS FREEMAN: Open Payments
NPI 1750971628 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 80 payments from 26 companies in 2025. Trend: 2023 $1,619 · 2024 $1,421 · 2025 $1,703
Food & beverage: $1,673Education: $31
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $215 |
| Merck Sharp & Dohme LLC | 9 | $199 |
| Janssen Biotech, Inc. | 9 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $167 |
| PFIZER INC. | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Eisai Inc. | 3 | $68 |
| SOBI, INC | 3 | $64 |
| Gilead Sciences, Inc. | 3 | $62 |
| ARRAY BIOPHARMA INC | 3 | $60 |
Products named: KEYTRUDA, INJECTAFER, NINLARO, Enhertu, ERLEADA, DARZALEX, Lenvima, LUTATHERA.
Industry payments across NC — which companies pay providers there.
